期刊
VACCINES
卷 10, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/vaccines10122073
关键词
SARS-CoV-2; COVID-19; vaccine; vaccination; hepatitis; autoimmune hepatitis; AIH; autoimmune liver injury; immune-mediated liver injury; review
There is an increasing number of AIH-like cases following SARS-CoV-2 vaccination, with most cases requiring immunosuppressive therapy. Early diagnosis is crucial, especially for patients with pre-existing liver disease.
Background: There is an increasing number of liver injury cases resembling autoimmune hepatitis (AIH) following SARS-CoV-2 vaccination; however, an association has not yet been established. Methods/Materials: A literature review was performed to identify articles regarding the association of AIH with vaccination, emphasizing on SARS-CoV-2 vaccines, and the proposed mechanisms. We then performed a literature search for AIH-like cases following SARS-CoV-2 vaccination, and we evaluated the included cases for AIH diagnosis using simplified diagnostic criteria (SDC), and for vaccination causality using the Naranjo score for adverse drug reactions. Results: We identified 51 AIH-like cases following SARS-CoV-2 vaccination. Forty cases (80%) were characterized as probable, at least probable, or definite for AIH diagnosis according to SDC. Forty cases (78.4%) were characterized as probable, four (7.8%) as possible, and three (5.8%) as definite for vaccine-related AIH according to the Naranjo score. Conclusion: SARS-CoV-2 vaccine-related AIH carries several phenotypes and, although most cases resolve, immunosuppressive therapy seems to be necessary. Early diagnosis is mandatory and should be considered in any patient with acute or chronic hepatitis after SARS-CoV-2 vaccination, especially in those with pre-existing liver disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据